Perfadex solution provides excellent lung preservation in contrast to Euro-Collins solution. Supplementation of the NO pathway by adding nitroglycerin to Perfadex solution can further optimize postischemic lung function by providing beneficial dilatory effects to the pulmonary vasculature and might therefore represent an easily applicable tool in clinical lung transplantation.
Surgery for Congenital Heart Disease (CHD) 1229 Midterm results after restoration of the morphologically left ventricle to the systemic circulation in patients with congenitally corrected transposition of the great arteries
Stephen M. Langley, MD, FRCS (CTh), David S. Winlaw, FRACS, Oliver Stumper, MD, Rami Dhillon, MRCP, Joseph V. de Giovanni, FRCP, John G. Wright, FRCP, Paul Miller, MRCP, Babulal Sethia, FRCS, David J. Barron, MD, FRCS (CTh), and William J. Brawn, FRCS, FRACS, Birmingham, United Kingdom Fifty-four patients underwent anatomic correction of congenitally corrected transposition of the great arteries. Early mortality was 5.6%, and 9-year was survival was 89.7%, with 94% of survivors in New York Heart Association functional class I. Continued surveillance is necessary to determine the functions of the aortic valve and of the morphologically left ventricle in the systemic circulation.
